Kok TC - Search Results

1

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy.

Polee MB, Hop WC, Kok TC, Eskens FA, van der Burg ME, Splinter TA, Siersema PD, Tilanus HW, Stoter G, van der Gaast A. Polee MB, et al. Among authors: kok tc. Br J Cancer. 2003 Dec 1;89(11):2045-50. doi: 10.1038/sj.bjc.6601364. Br J Cancer. 2003. PMID: 14647136 Free PMC article.

2

Ifosfamide in advanced adenocarcinoma of the oesophagus or oesophageal-gastric junction area. Rotterdam Esophageal Tumor Study Group.

Kok TC, van der Gaast A, Splinter TA, Tilanus HW. Kok TC, et al. Eur J Cancer. 1991;27(9):1112-4. doi: 10.1016/0277-5379(91)90305-w. Eur J Cancer. 1991. PMID: 1835618

3

Evaluation of CA19-9 serum levels for monitoring disease activity during chemotherapy of pancreatic adenocarcinoma.

Bac DJ, Kok TC, van der Gaast A, Splinter TA. Bac DJ, et al. Among authors: kok tc. J Cancer Res Clin Oncol. 1991;117(3):263-5. doi: 10.1007/BF01625436. J Cancer Res Clin Oncol. 1991. PMID: 2033095

4

Etoposide and cisplatin in advanced esophageal cancer. A preliminary report.

Kok TC, Splinter TA, Verweij J. Kok TC, et al. Acta Oncol. 1988;27(6b):807-9. doi: 10.3109/02841868809094362. Acta Oncol. 1988. PMID: 3233166

5

Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.

van der Gaast A, Schoenmakers CH, Kok TC, Blijenberg BG, Cornillie F, Splinter TA. van der Gaast A, et al. Among authors: kok tc. Br J Cancer. 1994 Mar;69(3):525-8. doi: 10.1038/bjc.1994.95. Br J Cancer. 1994. PMID: 7510117 Free PMC article.

6

Prognostic significance of tissue polypeptide-specific antigen (TPS) in patients with advanced non-small cell lung cancer.

van der Gaast A, Schoenmakers CH, Kok TC, Blijenberg BG, Hop WC, Splinter TA. van der Gaast A, et al. Among authors: kok tc. Eur J Cancer. 1994;30A(12):1783-6. doi: 10.1016/0959-8049(94)00214-p. Eur J Cancer. 1994. PMID: 7880606

7

Neoadjuvant treatment in oesophageal cancer: the needs for future trials. The Rotterdam Esophageal Tumor Study Group.

Kok TC, Tilanus HW. Kok TC, et al. Eur J Surg Oncol. 1996 Aug;22(4):323-5. doi: 10.1016/s0748-7983(96)90066-9. Eur J Surg Oncol. 1996. PMID: 8783644 Review.

8

Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.

Kok TC, Van der Gaast A, Dees J, Eykenboom WM, Van Overhagen H, Stoter G, Tilanus HW, Splinter TA. Kok TC, et al. Br J Cancer. 1996 Sep;74(6):980-4. doi: 10.1038/bjc.1996.469. Br J Cancer. 1996. PMID: 8826870 Free PMC article. Clinical Trial.

9

A phase I dose finding study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced esophageal cancer.

van der Gaast A, Kok TC, Vos R, Kerkhofs L, Splinter TA. van der Gaast A, et al. Among authors: kok tc. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-82-S19-85. Semin Oncol. 1997. PMID: 9427273 Clinical Trial.

10

Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer.

van der Gaast A, Kok TC, Kerkhofs L, Siersema PD, Tilanus HW, Splinter TA. van der Gaast A, et al. Among authors: kok tc. Br J Cancer. 1999 Jun;80(7):1052-7. doi: 10.1038/sj.bjc.6690462. Br J Cancer. 1999. PMID: 10362115 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters